United Therapeutics | UTHR - Umsatzerlöse

Aktienkurs
568.58
Täglich Wechseln
-7.21 -1.25%
Monatlich
-2.06%
Jährlich
86.21%
Q2 Prognose
557.15




Der Umsatz Veränderung Datum
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
Baxter International USD 2.7B 270M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
Insmed USD 305.96M 42.16M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Moderna USD 389M 289M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03